Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06164717 · ClinicalTrials.gov registry record · NA

Behavioral and Neural Characteristics of Adaptive Speech Motor Control

A NA study of Speech, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
507
Enrollment target
1
Study location

NCT06164717 is a NA study of Speech that is actively recruiting participants, run by University of Washington. The registered enrollment target is 507 participants, above the 119-participant average among 9 other Speech trials with a reported enrollment target (326% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06164717, a NA study of Speech, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
507 participants
Enrollment target
1
Study location

Study Summary

This study meets the NIH definition of a clinical trial, but is not a treatment study. Instead, the goal of this study is to investigate how hearing ourselves speak affects the planning and execution of speech movements. The study investigates this topic in both typical speakers and in patients with Deep Brain Stimulation (DBS) implants. The main questions it aims to answer are: * Does the way we hear our own speech while talking affect future speech movements? * Can the speech of DBS patients reveal which brain areas are involved in adjusting speech movements? Participants will read words, sentences, or series of random syllables from a computer monitor while their speech is being recorded. For some participants, an electrode cap is also used to record brain activity during these tasks. And for DBS patients, the tasks will be performed with the stimulator ON and with the stimulator OFF.

Conditions Studied

Interventions

  • BEHAVIORAL Auditory feedback perturbation during speech
  • BEHAVIORAL Visual feedback perturbation during reaching
  • OTHER DBS stimulation ON/OFF

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 507 participants
Start Date 2023-01-01
Est. Completion 2027-12-31
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT06164717

The ClinicalTrials.gov registry entry for NCT06164717 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 507 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 9 other Speech trials with a reported enrollment target (326% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Speech appearing as the primary indexed condition, and to 3 interventions - of which Auditory feedback perturbation during speech is the first listed.

NCT06164717 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT06164717 about?

NCT06164717 is a clinical study titled "Behavioral and Neural Characteristics of Adaptive Speech Motor Control". This study meets the NIH definition of a clinical trial, but is not a treatment study. Instead, the goal of this study is to investigate how hearing ourselves speak affects the planning and execution of speech movements. The study investigates this topic in both typical speakers and in patients with...

What is the current status of trial NCT06164717?

This trial is currently recruiting. It is a NA study. The enrollment target is 507 participants. The study started on 2023-01-01. Estimated completion is 2027-12-31.

What conditions does trial NCT06164717 study?

This clinical trial studies the following conditions: Speech.

What interventions are being tested in trial NCT06164717?

The interventions under investigation include: Auditory feedback perturbation during speech (BEHAVIORAL), Visual feedback perturbation during reaching (BEHAVIORAL), DBS stimulation ON/OFF (OTHER).

Who is sponsoring clinical trial NCT06164717?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06164717 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Speech

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.